Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
41
FMCQF Quote, Financials, Valuation and Earnings
Last price:
$44.25
Seasonality move
:
2.31%
Day range:
$44.25 - $44.25
52-week range:
$44.25 - $61.84
Dividend yield:
3.67%
P/E ratio:
11.51x
P/S ratio:
0.58x
P/B ratio:
0.79x
Volume:
--
Avg. volume:
46
1-year change:
-9.84%
Market cap:
$12.4B
Revenue:
$22.2B
EPS (TTM):
$3.84
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FMCQF
Fresenius Medical Care AG
|
$5.6B | -- | 6.34% | -- | -- |
|
BNTX
BioNTech SE
|
$201.5M | -$1.97 | -7.26% | -35.17% | $130.51 |
|
FSNUY
Fresenius SE & Co. KGaA
|
-- | -- | -- | -- | -- |
|
IFRX
InflaRx NV
|
$6.4K | -$0.14 | -74.55% | -23.33% | $8.84 |
|
MDGEF
Medigene AG
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FMCQF
Fresenius Medical Care AG
|
$44.25 | -- | $12.4B | 11.51x | $1.62 | 3.67% | 0.58x |
|
BNTX
BioNTech SE
|
$91.18 | $130.51 | $23.4B | 191.55x | $0.00 | 0% | 6.64x |
|
FSNUY
Fresenius SE & Co. KGaA
|
$12.57 | -- | $28B | 19.47x | $0.28 | 2.28% | 1.08x |
|
IFRX
InflaRx NV
|
$0.91 | $8.84 | $66.6M | -- | $0.00 | 0% | 281.78x |
|
MDGEF
Medigene AG
|
-- | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FMCQF
Fresenius Medical Care AG
|
44.79% | 2.167 | 89.7% | 0.80x |
|
BNTX
BioNTech SE
|
1.37% | 1.157 | 1.31% | 7.36x |
|
FSNUY
Fresenius SE & Co. KGaA
|
38.45% | 2.011 | 42.39% | 0.68x |
|
IFRX
InflaRx NV
|
2.1% | -3.295 | 1.26% | 2.34x |
|
MDGEF
Medigene AG
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FMCQF
Fresenius Medical Care AG
|
$1.6B | $672.7M | 4.72% | 8.19% | 11.4% | $668M |
|
BNTX
BioNTech SE
|
$668.2M | -$271M | -5.85% | -5.93% | -25.66% | $277M |
|
FSNUY
Fresenius SE & Co. KGaA
|
$1.8B | $616.9M | 4.9% | 8.16% | 8.61% | $704.8M |
|
IFRX
InflaRx NV
|
-$89.2K | -$11.7M | -80.95% | -82.01% | -42057.91% | -$11.4M |
|
MDGEF
Medigene AG
|
-- | -- | -- | -- | -- | -- |
Fresenius Medical Care AG vs. Competitors
-
Which has Higher Returns FMCQF or BNTX?
BioNTech SE has a net margin of 7.95% compared to Fresenius Medical Care AG's net margin of -33.61%. Fresenius Medical Care AG's return on equity of 8.19% beat BioNTech SE's return on equity of -5.93%.
Company Gross Margin Earnings Per Share Invested Capital FMCQFFresenius Medical Care AG27.4% $1.33 $29.5B BNTXBioNTech SE63.27% -$1.45 $22.9B -
What do Analysts Say About FMCQF or BNTX?
Fresenius Medical Care AG has a consensus price target of --, signalling downside risk potential of --. On the other hand BioNTech SE has an analysts' consensus of $130.51 which suggests that it could grow by 43.13%. Given that BioNTech SE has higher upside potential than Fresenius Medical Care AG, analysts believe BioNTech SE is more attractive than Fresenius Medical Care AG.
Company Buy Ratings Hold Ratings Sell Ratings FMCQFFresenius Medical Care AG0 0 0 BNTXBioNTech SE13 5 0 -
Is FMCQF or BNTX More Risky?
Fresenius Medical Care AG has a beta of 0.860, which suggesting that the stock is 13.993% less volatile than S&P 500. In comparison BioNTech SE has a beta of 1.581, suggesting its more volatile than the S&P 500 by 58.073%.
-
Which is a Better Dividend Stock FMCQF or BNTX?
Fresenius Medical Care AG has a quarterly dividend of $1.62 per share corresponding to a yield of 3.67%. BioNTech SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fresenius Medical Care AG pays 44.35% of its earnings as a dividend. BioNTech SE pays out -- of its earnings as a dividend. Fresenius Medical Care AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FMCQF or BNTX?
Fresenius Medical Care AG quarterly revenues are $5.9B, which are larger than BioNTech SE quarterly revenues of $1.1B. Fresenius Medical Care AG's net income of $469.1M is higher than BioNTech SE's net income of -$355M. Notably, Fresenius Medical Care AG's price-to-earnings ratio is 11.51x while BioNTech SE's PE ratio is 191.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fresenius Medical Care AG is 0.58x versus 6.64x for BioNTech SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FMCQFFresenius Medical Care AG0.58x 11.51x $5.9B $469.1M BNTXBioNTech SE6.64x 191.55x $1.1B -$355M
-
Which has Higher Returns FMCQF or FSNUY?
Fresenius SE & Co. KGaA has a net margin of 7.95% compared to Fresenius Medical Care AG's net margin of 6.94%. Fresenius Medical Care AG's return on equity of 8.19% beat Fresenius SE & Co. KGaA's return on equity of 8.16%.
Company Gross Margin Earnings Per Share Invested Capital FMCQFFresenius Medical Care AG27.4% $1.33 $29.5B FSNUYFresenius SE & Co. KGaA24.76% $0.19 $37.2B -
What do Analysts Say About FMCQF or FSNUY?
Fresenius Medical Care AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Fresenius SE & Co. KGaA has an analysts' consensus of -- which suggests that it could fall by --. Given that Fresenius Medical Care AG has higher upside potential than Fresenius SE & Co. KGaA, analysts believe Fresenius Medical Care AG is more attractive than Fresenius SE & Co. KGaA.
Company Buy Ratings Hold Ratings Sell Ratings FMCQFFresenius Medical Care AG0 0 0 FSNUYFresenius SE & Co. KGaA0 0 0 -
Is FMCQF or FSNUY More Risky?
Fresenius Medical Care AG has a beta of 0.860, which suggesting that the stock is 13.993% less volatile than S&P 500. In comparison Fresenius SE & Co. KGaA has a beta of 0.810, suggesting its less volatile than the S&P 500 by 18.985%.
-
Which is a Better Dividend Stock FMCQF or FSNUY?
Fresenius Medical Care AG has a quarterly dividend of $1.62 per share corresponding to a yield of 3.67%. Fresenius SE & Co. KGaA offers a yield of 2.28% to investors and pays a quarterly dividend of $0.28 per share. Fresenius Medical Care AG pays 44.35% of its earnings as a dividend. Fresenius SE & Co. KGaA pays out -- of its earnings as a dividend. Fresenius Medical Care AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FMCQF or FSNUY?
Fresenius Medical Care AG quarterly revenues are $5.9B, which are smaller than Fresenius SE & Co. KGaA quarterly revenues of $7.2B. Fresenius Medical Care AG's net income of $469.1M is lower than Fresenius SE & Co. KGaA's net income of $497M. Notably, Fresenius Medical Care AG's price-to-earnings ratio is 11.51x while Fresenius SE & Co. KGaA's PE ratio is 19.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fresenius Medical Care AG is 0.58x versus 1.08x for Fresenius SE & Co. KGaA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FMCQFFresenius Medical Care AG0.58x 11.51x $5.9B $469.1M FSNUYFresenius SE & Co. KGaA1.08x 19.47x $7.2B $497M
-
Which has Higher Returns FMCQF or IFRX?
InflaRx NV has a net margin of 7.95% compared to Fresenius Medical Care AG's net margin of -51538.49%. Fresenius Medical Care AG's return on equity of 8.19% beat InflaRx NV's return on equity of -82.01%.
Company Gross Margin Earnings Per Share Invested Capital FMCQFFresenius Medical Care AG27.4% $1.33 $29.5B IFRXInflaRx NV-320.86% -$0.21 $54.4M -
What do Analysts Say About FMCQF or IFRX?
Fresenius Medical Care AG has a consensus price target of --, signalling downside risk potential of --. On the other hand InflaRx NV has an analysts' consensus of $8.84 which suggests that it could grow by 868.56%. Given that InflaRx NV has higher upside potential than Fresenius Medical Care AG, analysts believe InflaRx NV is more attractive than Fresenius Medical Care AG.
Company Buy Ratings Hold Ratings Sell Ratings FMCQFFresenius Medical Care AG0 0 0 IFRXInflaRx NV5 2 0 -
Is FMCQF or IFRX More Risky?
Fresenius Medical Care AG has a beta of 0.860, which suggesting that the stock is 13.993% less volatile than S&P 500. In comparison InflaRx NV has a beta of 1.493, suggesting its more volatile than the S&P 500 by 49.333%.
-
Which is a Better Dividend Stock FMCQF or IFRX?
Fresenius Medical Care AG has a quarterly dividend of $1.62 per share corresponding to a yield of 3.67%. InflaRx NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fresenius Medical Care AG pays 44.35% of its earnings as a dividend. InflaRx NV pays out -- of its earnings as a dividend. Fresenius Medical Care AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FMCQF or IFRX?
Fresenius Medical Care AG quarterly revenues are $5.9B, which are larger than InflaRx NV quarterly revenues of $27.8K. Fresenius Medical Care AG's net income of $469.1M is higher than InflaRx NV's net income of -$14.3M. Notably, Fresenius Medical Care AG's price-to-earnings ratio is 11.51x while InflaRx NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fresenius Medical Care AG is 0.58x versus 281.78x for InflaRx NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FMCQFFresenius Medical Care AG0.58x 11.51x $5.9B $469.1M IFRXInflaRx NV281.78x -- $27.8K -$14.3M
-
Which has Higher Returns FMCQF or MDGEF?
Medigene AG has a net margin of 7.95% compared to Fresenius Medical Care AG's net margin of --. Fresenius Medical Care AG's return on equity of 8.19% beat Medigene AG's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FMCQFFresenius Medical Care AG27.4% $1.33 $29.5B MDGEFMedigene AG-- -- -- -
What do Analysts Say About FMCQF or MDGEF?
Fresenius Medical Care AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Medigene AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Fresenius Medical Care AG has higher upside potential than Medigene AG, analysts believe Fresenius Medical Care AG is more attractive than Medigene AG.
Company Buy Ratings Hold Ratings Sell Ratings FMCQFFresenius Medical Care AG0 0 0 MDGEFMedigene AG0 0 0 -
Is FMCQF or MDGEF More Risky?
Fresenius Medical Care AG has a beta of 0.860, which suggesting that the stock is 13.993% less volatile than S&P 500. In comparison Medigene AG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FMCQF or MDGEF?
Fresenius Medical Care AG has a quarterly dividend of $1.62 per share corresponding to a yield of 3.67%. Medigene AG offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fresenius Medical Care AG pays 44.35% of its earnings as a dividend. Medigene AG pays out -- of its earnings as a dividend. Fresenius Medical Care AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FMCQF or MDGEF?
Fresenius Medical Care AG quarterly revenues are $5.9B, which are larger than Medigene AG quarterly revenues of --. Fresenius Medical Care AG's net income of $469.1M is higher than Medigene AG's net income of --. Notably, Fresenius Medical Care AG's price-to-earnings ratio is 11.51x while Medigene AG's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fresenius Medical Care AG is 0.58x versus -- for Medigene AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FMCQFFresenius Medical Care AG0.58x 11.51x $5.9B $469.1M MDGEFMedigene AG-- -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 4
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 4
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
